![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RENB market cap is 206.88M. The company's latest EPS is USD -0.2762 and P/E is -2.61.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -4.06M | -22.94M | -8.88M | -4.27M | -17.19M |
Net Income | -4.33M | -23.2M | -9.18M | -4.53M | -17.03M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -10.99M | -11.92M | -23.4M | -22.83M | -38.56M |
Net Income | -18.02M | -11.42M | -26.97M | -113.43M | -39.68M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 78.73M | 58.3M | 57.56M | 58.02M | 212.28M |
Total Liabilities | 12.6M | 11.8M | 10.82M | 14.42M | 43.68M |
Total Equity | 66.13M | 46.5M | 46.75M | 43.6M | 168.6M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 179.88M | 178.1M | 189.61M | 84.63M | 58.3M |
Total Liabilities | 6.78M | 11.83M | 14.94M | 12.01M | 11.8M |
Total Equity | 173.1M | 166.27M | 174.66M | 72.62M | 46.5M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -9.51M | -11.78M | -2.78M | -5.92M | -8.56M |
Investing | -24k | -30k | -1.06M | -1.12M | -1.21M |
Financing | 3.27M | 4.52M | 2.56M | 5.41M | 8.05M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -8.51M | -10.46M | -20.61M | -15.73M | -11.78M |
Investing | -717k | -185k | -49k | -5k | -30k |
Financing | 6.02M | 7.2M | 32.6M | 4.25M | 4.52M |
Market Cap | 206.88M |
Price to Earnings Ratio | -2.61 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 55.38 |
Price to Book Ratio | 2.22 |
Dividend Yield | - |
Shares Outstanding | 143.67M |
Average Volume (1 week) | 668.39k |
Average Volume (1 Month) | 1.36M |
52 Week Change | 65.52% |
52 Week High | 5.25 |
52 Week Low | 0.6601 |
Spread (Intraday) | 0.13 (9.03%) |
Company Name | Renovaro Inc |
Address |
108 w. 13th street suite 100 wilmington, delaware 19801 |
Website | https://renovarobio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions